Need to revisit step therapy for ARBs.
C Venkata
CV
Ram
Thomas
T
Giles
D047228:Angiotensin II Type 1 Receptor Blockers / Q000191:economics* / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use*; D002985:Clinical Protocols; D016527:Drug Costs; D004363:Drug Utilization; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D007345:Insurance Claim Review; D010349:Patient Compliance
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents